Repeat Cytology and Human Papillomavirus Screening Strategies in Detecting Preinvasive Cervical Lesions

被引:4
|
作者
Li, Kemin [1 ]
Yin, Rutie [1 ]
机构
[1] Sichuan Univ, West China Univ Hosp 2, Dept Gynaecol, Chengdu 610064, Sichuan, Peoples R China
关键词
RANDOMIZED-TRIAL; WOMEN; NEOPLASIA; ABNORMALITIES; PERSISTENCE; INFECTION;
D O I
10.1097/MD.0000000000000435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to determine the value of human papillomavirus (HPV) testing in screening patients with pre-invasive cervical lesions. Seven hundred thirty-four women diagnosed with atypical squamous cells of undetermined significance (ASCUS+) cervical cytology during routine screening had additional cytologic testing and HPV DNA testing within 6 months of their diagnosis, after which all women who tested positive were referred for colposcopy and biopsy. The test findings were then used to determine the screening value of HPV for diagnosing preinvasive cervical lesions. Cytology and HPV testing were compared by conventional cytology. The odds ratio (OR) of sensitivity usingASCUS+or low-grade squamous intraepithelial neoplasia (LSIL+) as a cutoff for detecting cervical intraepithelial neoplasia (CIN) II+ was, respectively, 0.78 (0.72, 0.85) and 0.82 (0.70, 0.95) (P < 0.01). The cytology for triage and conventional cytology had different sensitivities usingASCUS+ orLSIL+ as the cutoff (P < 0.01). The cytology or HPV testing and conventional cytology had a difference in sensitivity usingASCUS+, LSIL+, or high-grade squamous intraepithelial neoplasia (HSIL+) as the cutoff (P < 0.01). Cytology and HPV testing were also compared with conventional cytology. The OR of specificity usingASCUS+ orLSIL+ as the cutoff for the detection of CIN II+ was 1.97 (1.68, 2.31) and 1.10 (1.02, 1.18), respectively (P < 0.01). The cytology for triage and conventional cytology had a difference in specificity when ASCUS+ or LSIL+ was used as the cutoff (P < 0.01). Finally, the cytology or HPV testing and conventional cytology had a difference in specificity when ASCUS+, LSIL+, orHSIL+ was used as the cutoff (P < 0.01). Cytology and HPV testing and cytology for triage improved the specificity of detecting CIN II+, but this did not improve the sensitivity. Additionally, cytology or HPV testing improved the sensitivity of detecting CIN II+ but not the specificity.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy
    Porras, Carolina
    Wentzensen, Nicolas
    Rodriguez, Ana C.
    Morales, Jorge
    Burk, Robert D.
    Alfaro, Mario
    Hutchinson, Martha
    Herrero, Rolando
    Hildesheim, Allan
    Sherman, Mark E.
    Wacholder, Sholom
    Solomon, Diane
    Schiffman, Mark
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (08) : 1879 - 1887
  • [22] Extended Human Papillomavirus Genotype Distribution and Cervical Cytology Results in a Large Cohort of Chinese Women With Invasive Cervical Cancers and High-Grade Squamous Intraepithelial Lesions
    Jiang, Wei
    Austin, R. Marshall
    Li, Lei
    Yang, Kaixuan
    Zhao, Chengquan
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 (01) : 43 - 50
  • [23] Cervical Cancer Screening by Cytology and Human Papillomavirus Testing During Pregnancy in French Women With Poor Adhesion to Regular Cervical Screening
    Brun-Micaleff, Elisabeth
    Coffy, Amandine
    Rey, Valerie
    Didelot, Marie-Noelle
    Combecal, Jacques
    Doutre, Sylviane
    Daures, Jean-Pierre
    Segondy, Michel
    Boulle, Nathalie
    JOURNAL OF MEDICAL VIROLOGY, 2014, 86 (03) : 536 - 545
  • [24] 16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
    Reboilj, Matejka
    Brentnall, Adam R.
    Mathews, Christopher
    Denton, Karin
    Holbrook, Miles
    Levine, Tanya
    Sargent, Alexandra
    Smith, John
    Tidy, John
    Tyler, Xenia
    Kitchener, Henry
    Ellis, Kay
    Evans, Chris
    Frew, Viki
    Giles, Thomas
    Hunt, Katherine
    Moss, Sue
    Parker, Janet
    Patnick, Julietta
    Rimmer, Janet
    Smith, David
    Stubbs, Ruth
    Tidbury, Penelope
    BRITISH JOURNAL OF CANCER, 2019, 121 (06) : 455 - 463
  • [25] Genotyping of human papillomavirus in triaging of low-grade cervical cytology
    Soderlund-Strand, Anna
    Eklund, Carina
    Kemetli, Levent
    Grillner, Lena
    Tornberg, Sven
    Dillner, Joakim
    Dillner, Lena
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (02) : 145.e1 - 145.e6
  • [26] Prevalence of Human Papillomavirus Among Women With Normal Cervical Cytology in Kuwait
    Al-Awadhi, Rana
    Chehadeh, Wassim
    Kapila, Kusum
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (03) : 453 - 460
  • [27] Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination
    Grimes, David Robert
    Corry, Edward M. A.
    Malagon, Talia
    O'Riain, Ciaran
    Franco, Eduardo L.
    Brennan, Donal J.
    JAMA NETWORK OPEN, 2021, 4 (06)
  • [28] Comprehensive insights into human papillomavirus and cervical cancer: Pathophysiology, screening, and vaccination strategies
    Liu, Ying
    Ai, Hao
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (06):
  • [29] Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
    van Rosmalen, J.
    de Kok, I. M. C. M.
    van Ballegooijen, M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (06) : 699 - 709
  • [30] Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg
    Latsuzbaia, Ardashel
    Hebette, Gaetan
    Fischer, Marc
    Arbyn, Marc
    Weyers, Steven
    Vielh, Philippe
    Schmitt, Fernando
    Mossong, Joel
    DIAGNOSTIC CYTOPATHOLOGY, 2017, 45 (05) : 384 - 390